{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T18:26:53Z","timestamp":1792175213564,"version":"4.4.0"},"reference-count":112,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T00:00:00Z","timestamp":1762992000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["TropicalMed"],"abstract":"<jats:p>This study aimed to assess the prevalence and reporting rate of adverse events following immunization (AEFIs) among healthcare professionals (HCPs) and students of health-related disciplines after COVID-19 vaccination. It was conducted at the beginning of the vaccination campaign in Poland (February 2021), when vaccines were only available to limited groups of recipients, mainly those related to healthcare. Questionnaires were distributed among HCPs in the Pomeranian voivodeship (N = 1063) and students at the Medical University of Gda\u0144sk (N = 1506). The primary objective was to compare respondents\u2019 self-reported AEFI notifications with official reports published by the National Sanitary Inspectorate. A total of 240 participants declared having reported at least one AEFI, whereas official reports from the same period indicated that only 194 individuals had reported AEFIs in the entire voivodeship. This translates into significant differences in notification rates (14.9% and 0.09%, respectively). A detailed breakdown into local and systemic AEFIs also revealed significant discrepancies with official reports (850 vs. 329 and 1137 vs. 46, respectively). The most common reasons for not reporting were managing the symptoms on one\u2019s own and perceiving the symptoms as not severe enough to report. Underreporting of AEFIs is an issue that requires attention from both the scientific community and public health authorities, as it may hinder reliable vaccine safety assessment and contribute to increased vaccine hesitancy.<\/jats:p>","DOI":"10.3390\/tropicalmed10110320","type":"journal-article","created":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T09:06:36Z","timestamp":1763111196000},"page":"320","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Underreporting of Adverse Events Following COVID-19 Vaccination Among Healthcare Professionals in Poland: Potential Implications for Vaccine Hesitancy"],"prefix":"10.3390","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0638-4565","authenticated-orcid":false,"given":"Jakub","family":"Grabowski","sequence":"first","affiliation":[{"name":"Division of Developmental, Psychotic and Geriatric Psychiatry, Department of Psychiatry, Faculty of Medicine, Medical University of Gda\u0144sk, 80-282 Gda\u0144sk, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7795-656X","authenticated-orcid":false,"given":"Anna","family":"Niebrzydowska","sequence":"additional","affiliation":[{"name":"Regional Psychiatric Hospital, 80-282 Gda\u0144sk, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-0354-5635","authenticated-orcid":false,"given":"Aleksandra","family":"Brzozowska","sequence":"additional","affiliation":[{"name":"Adult Psychiatry Scientific Circle, Division of Developmental, Psychotic and Geriatric Psychiatry, Department of Psychiatry, Faculty of Medicine, Medical University of Gda\u0144sk, 80-282 Gda\u0144sk, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5749-2611","authenticated-orcid":false,"given":"Przemys\u0142aw","family":"Waszak","sequence":"additional","affiliation":[{"name":"Department of Hygiene and Epidemiology, Faculty of Medicine, Medical University of Gda\u0144sk, 80-210 Gda\u0144sk, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2809-0955","authenticated-orcid":false,"given":"Pawe\u0142","family":"Zago\u017cd\u017con","sequence":"additional","affiliation":[{"name":"Department of Hygiene and Epidemiology, Faculty of Medicine, Medical University of Gda\u0144sk, 80-210 Gda\u0144sk, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0005-8830","authenticated-orcid":false,"given":"Shan","family":"Ali","sequence":"additional","affiliation":[{"name":"Neurology Department, Mayo Clinic, Jacksonville, FL 32224, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-1618-2208","authenticated-orcid":false,"given":"Tomasz","family":"Brancewicz","sequence":"additional","affiliation":[{"name":"Optimmed Mental Health Centre, 80-767 Gda\u0144sk, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1783-2140","authenticated-orcid":false,"given":"Monika","family":"Wolff","sequence":"additional","affiliation":[{"name":"Adult Psychiatry Scientific Circle, Division of Developmental, Psychotic and Geriatric Psychiatry, Department of Psychiatry, Faculty of Medicine, Medical University of Gda\u0144sk, 80-282 Gda\u0144sk, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0734-997X","authenticated-orcid":false,"given":"Aleksandra","family":"Macul-Sanewska","sequence":"additional","affiliation":[{"name":"Adult Psychiatry Scientific Circle, Division of Developmental, Psychotic and Geriatric Psychiatry, Department of Psychiatry, Faculty of Medicine, Medical University of Gda\u0144sk, 80-282 Gda\u0144sk, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4373-5459","authenticated-orcid":false,"given":"Leszek","family":"Bidzan","sequence":"additional","affiliation":[{"name":"Division of Developmental, Psychotic and Geriatric Psychiatry, Department of Psychiatry, Faculty of Medicine, Medical University of Gda\u0144sk, 80-282 Gda\u0144sk, Poland"},{"name":"Department of Health Sciences, Pomeranian University in S\u0142upsk, 76-200 S\u0142upsk, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,11,13]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ijid.2020.03.004","article-title":"The SARS-CoV-2 Outbreak: What We Know","volume":"94","author":"Wu","year":"2020","journal-title":"Int. J. Infect. Dis."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1213\/ANE.0000000000004845","article-title":"Coronaviruses and SARS-CoV-2: A Brief Overview","volume":"131","author":"Ludwig","year":"2020","journal-title":"Anesth. Analg."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1021\/acscentsci.1c00120","article-title":"A Comprehensive Review of the Global Efforts on COVID-19 Vaccine Development","volume":"7","author":"Li","year":"2021","journal-title":"ACS Cent. Sci."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/d41573-020-00073-5","article-title":"The COVID-19 Vaccine Development Landscape","volume":"19","author":"Andreadakis","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/s41418-020-00720-9","article-title":"COVID-19 Vaccines: Where We Stand and Challenges Ahead","volume":"28","author":"Forni","year":"2021","journal-title":"Cell Death Differ."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/s41562-021-01122-8","article-title":"A Global Database of COVID-19 Vaccinations","volume":"5","author":"Mathieu","year":"2021","journal-title":"Nat. Hum. Behav."},{"key":"ref_7","unstructured":"(2025, August 07). COVID-19 Medicines. Available online: https:\/\/www.ema.europa.eu\/en\/human-regulatory-overview\/public-health-threats\/coronavirus-disease-covid-19\/covid-19-medicines."},{"key":"ref_8","unstructured":"(2025, November 10). Poland Country Snapshot: Public Health Agencies and Services in the Response to COVID-19. Available online: https:\/\/eurohealthobservatory.who.int\/news-room\/articles\/item\/poland-country-snapshot-public-health-agencies-and-services-in-the-response-to-covid-19."},{"key":"ref_9","unstructured":"(2025, August 17). COVID-19 Vaccines: Safety Surveillance Manual, Second Edition. Available online: https:\/\/www.who.int\/publications\/i\/item\/9789240032781."},{"key":"ref_10","unstructured":"(2025, August 17). Global Manual on Surveillance of Adverse Events Following Immunization. Available online: https:\/\/www.who.int\/publications\/i\/item\/9789241507769."},{"key":"ref_11","unstructured":"(2025, August 17). Submitting a Vaccine Adverse Event Reporting System (VAERS) Report and Using VAERS Data, Available online: https:\/\/www.cdc.gov\/vaccine-safety-systems\/vaers\/access-use.html."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and Efficacy of the BNT162b2 mRNA COVID-19 Vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1111\/all.14739","article-title":"EAACI Statement on the Diagnosis, Management and Prevention of Severe Allergic Reactions to COVID-19 Vaccines","volume":"76","author":"Sokolowska","year":"2021","journal-title":"Allergy"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1056\/NEJMoa2110345","article-title":"Safety and Efficacy of the BNT162b2 mRNA COVID-19 Vaccine through 6 Months","volume":"385","author":"Thomas","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/s41541-023-00657-3","article-title":"Adverse Effects, Perceptions and Attitudes Related to BNT162b2, mRNA-1273 or JNJ-78436735 SARS-CoV-2 Vaccines: Population-Based Cohort","volume":"8","author":"Menges","year":"2023","journal-title":"npj Vaccines"},{"key":"ref_16","first-page":"e23526","article-title":"Pfizer-BioNTech COVID-19 Vaccine (BNT162b2) Side Effects: A Systematic Review","volume":"14","author":"Dighriri","year":"2022","journal-title":"Cureus"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1056\/NEJMoa2200674","article-title":"Safety and Efficacy of a Third Dose of BNT162b2 COVID-19 Vaccine","volume":"386","author":"Moreira","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"ref_18","unstructured":"(2025, August 07). Czym s\u0105 Niepo\u017c\u0105dane Odczyny Poszczepienne, Available online: https:\/\/szczepienia.pzh.gov.pl\/wszystko-o-szczepieniach\/co-to-sa-niepozadane-odczyny-poszczepienne-2\/."},{"key":"ref_19","unstructured":"(2025, August 07). Comirnaty. Available online: https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/comirnaty."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Hon, B.Y.C., Chan, J., Ng, K.S., and Lam, S.C. (2024). Predicting Herd Immunity Achievement: A Time-Series Analysis of Vaccination and Fatality Rates Using 1075 Days of COVID-19 Data. Front. Public Health, 12.","DOI":"10.3389\/fpubh.2024.1403163"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/s43856-022-00075-x","article-title":"Modelling the Impact of Vaccine Hesitancy in Prolonging the Need for Non-Pharmaceutical Interventions to Control the COVID-19 Pandemic","volume":"2","author":"Hogan","year":"2022","journal-title":"Commun. Med."},{"key":"ref_22","first-page":"100191","article-title":"County-Level Vaccination Coverage and Rates of COVID-19 Cases and Deaths in the United States: An Ecological Analysis","volume":"9","author":"McLaughlin","year":"2022","journal-title":"Lancet Reg. Health"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"100213","DOI":"10.1016\/j.jvacx.2022.100213","article-title":"Trust Is the Common Denominator for COVID-19 Vaccine Acceptance: A Literature Review","volume":"12","author":"Adhikari","year":"2022","journal-title":"Vaccine X"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Stojanovic, J., Boucher, V.G., Gagne, M., Gupta, S., Joyal-Desmarais, K., Paduano, S., Aburub, A.S., Sheinfeld Gorin, S.N., Kassianos, A.P., and Ribeiro, P.A.B. (2021). Global Trends and Correlates of COVID-19 Vaccination Hesitancy: Findings from the iCARE Study. Vaccines, 9.","DOI":"10.3390\/vaccines9060661"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Yasmin, F., Najeeb, H., Moeed, A., Naeem, U., Asghar, M.S., Chughtai, N.U., Yousaf, Z., Seboka, B.T., Ullah, I., and Lin, C.-Y. (2021). COVID-19 Vaccine Hesitancy in the United States: A Systematic Review. Front. Public Health, 9.","DOI":"10.3389\/fpubh.2021.770985"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Sallam, M. (2021). COVID-19 Vaccine Hesitancy Worldwide: A Concise Systematic Review of Vaccine Acceptance Rates. Vaccines, 9.","DOI":"10.1101\/2020.12.28.20248950"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s41256-022-00255-1","article-title":"COVID-19 Vaccine Hesitancy in Africa: A Scoping Review","volume":"7","author":"Ackah","year":"2022","journal-title":"Glob. Health Res. Policy"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Biswas, M.R., Alzubaidi, M.S., Shah, U., Abd-Alrazaq, A.A., and Shah, Z. (2021). A Scoping Review to Find Out Worldwide COVID-19 Vaccine Hesitancy and Its Underlying Determinants. Vaccines, 9.","DOI":"10.3390\/vaccines9111243"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Bahreini, R., Sardareh, M., and Arab-Zozani, M. (2024). A Scoping Review of COVID-19 Vaccine Hesitancy: Refusal Rate, Associated Factors, and Strategies to Reduce. Front. Public Health, 12.","DOI":"10.3389\/fpubh.2024.1382849"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"daac078","DOI":"10.1093\/heapro\/daac078","article-title":"COVID-19 Vaccine Hesitancy and Acceptance: A Comprehensive Scoping Review of Global Literature","volume":"37","author":"Majid","year":"2022","journal-title":"Health Promot. Int."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1950504","DOI":"10.1080\/21645515.2021.1950504","article-title":"COVID-19 Vaccine Hesitancy: Misinformation and Perceptions of Vaccine Safety","volume":"18","author":"Kricorian","year":"2022","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Aw, J., Seng, J.J.B., Seah, S.S.Y., and Low, L.L. (2021). COVID-19 Vaccine Hesitancy\u2014A Scoping Review of Literature in High-Income Countries. Vaccines, 9.","DOI":"10.3390\/vaccines9080900"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Prieto-Campo, \u00c1., V\u00e1zquez-Cancela, O., Roque, F., Herdeiro, M.T., Figueiras, A., and Zapata-Cachafeiro, M. (2024). Unmasking Vaccine Hesitancy and Refusal: A Deep Dive into Anti-Vaxxer Perspectives on COVID-19 in Spain. BMC Public Health, 24.","DOI":"10.1186\/s12889-024-18864-5"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.puhe.2021.02.025","article-title":"Vaccine Hesitancy in the Era of COVID-19","volume":"194","author":"Troiano","year":"2021","journal-title":"Public Health"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Abate, B.B., Tilahun, B.D., and Yayeh, B.M. (2024). Global COVID-19 Vaccine Acceptance Level and Its Determinants: An Umbrella Review. BMC Public Health, 24.","DOI":"10.1186\/s12889-023-17497-4"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.4161\/hv.24657","article-title":"Vaccine Hesitancy: An Overview","volume":"9","author":"Laberge","year":"2013","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s00103-019-03063-0","article-title":"Understanding Vaccine Acceptance and Demand\u2014And Ways to Increase Them","volume":"63","author":"Habersaat","year":"2020","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Azarpanah, H., Farhadloo, M., Vahidov, R., and Pilote, L. (2021). Vaccine Hesitancy: Evidence from an Adverse Events Following Immunization Database, and the Role of Cognitive Biases. BMC Public Health, 21.","DOI":"10.1186\/s12889-021-11745-1"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"e2023054","DOI":"10.4178\/epih.e2023054","article-title":"Barriers to COVID-19 Vaccine Surveillance: The Issue of under-Reporting Adverse Events","volume":"45","author":"Noh","year":"2023","journal-title":"Epidemiol. Health"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1002\/pds.5605","article-title":"Reporting Rates for VAERS Death Reports Following COVID-19 Vaccination, December 14, 2020\u2013November 17, 2021","volume":"32","author":"Day","year":"2023","journal-title":"Pharmacoepidemiol. Drug"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"7458","DOI":"10.1016\/j.vaccine.2020.09.072","article-title":"The Reporting Sensitivity of the Vaccine Adverse Event Reporting System (VAERS) for Anaphylaxis and for Guillain-Barr\u00e9 Syndrome","volume":"38","author":"Miller","year":"2020","journal-title":"Vaccine"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Hodel, K.V.S., Fiuza, B.S.D., Concei\u00e7\u00e3o, R.S., Aleluia, A.C.M., Pitanga, T.N., Fonseca, L.M.d.S., Valente, C.O., Minafra-Rezende, C.S., and Machado, B.A.S. (2024). Pharmacovigilance in Vaccines: Importance, Main Aspects, Perspectives, and Challenges\u2014A Narrative Review. Pharmaceuticals, 17.","DOI":"10.3390\/ph17060807"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"385","DOI":"10.2165\/00002018-200629050-00003","article-title":"Under-Reporting of Adverse Drug Reactions","volume":"29","author":"Hazell","year":"2006","journal-title":"Drug Safety"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s40801-025-00492-z","article-title":"Understanding Underreporting of Adverse Drug Reactions in the Philippines: A Mixed Methods Study","volume":"12","author":"Lirasan","year":"2025","journal-title":"Drugs Real World Outcomes"},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Nadew, S.S., Beyene, K.G., and Beza, S.W. (2020). Adverse Drug Reaction Reporting Practice and Associated Factors among Medical Doctors in Government Hospitals in Addis Ababa, Ethiopia. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0227712"},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Sandberg, A., Salminen, V., Heinonen, S., and Siv\u00e9n, M. (2022). Under-Reporting of Adverse Drug Reactions in Finland and Healthcare Professionals\u2019 Perspectives on How to Improve Reporting. Healthcare, 10.","DOI":"10.3390\/healthcare10061015"},{"key":"ref_47","unstructured":"(2025, August 07). COVID 19 AEFIs Poland 2021 [Research Data]. Available online: https:\/\/figshare.com\/articles\/dataset\/COVID_19_AEFIs_Poland_2021_research_data_\/29348090."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Dziedzic, A., Riad, A., Attia, S., Klugar, M., and Tanasiewicz, M. (2021). Self-Reported Adverse Events of COVID-19 Vaccines in Polish Healthcare Workers and Medical Students. Cross-Sectional Study and Pooled Analysis of CoVaST Project Results in Central Europe. J. Clin. Med., 10.","DOI":"10.3390\/jcm10225338"},{"key":"ref_49","first-page":"477","article-title":"Side Effects among Healthcare Workers from a Large Milan University Hospital after Second Dose of BNT162b2 mRNA COVID-19 Vaccine","volume":"112","author":"Borroni","year":"2021","journal-title":"Med. Lav."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s10900-021-01039-3","article-title":"Active Surveillance of Adverse Events in Healthcare Workers Recipients After Vaccination with COVID-19 BNT162b2 Vaccine (Pfizer-BioNTech, Comirnaty): A Cross-Sectional Study","volume":"47","author":"Ripabelli","year":"2022","journal-title":"J. Community Health"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.3349\/ymj.2021.62.12.1162","article-title":"Adverse Events with the Pfizer-BioNTech COVID-19 Vaccine among Korean Healthcare Workers","volume":"62","author":"Im","year":"2021","journal-title":"Yonsei Med. J."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1007\/s40264-025-01547-4","article-title":"Signal Monitoring for Adverse Events Following Immunisation with COVID-19 Vaccines During the SARS-CoV-2 Pandemic: An Evaluation of the South African Surveillance System","volume":"48","author":"Sankar","year":"2025","journal-title":"Drug Saf."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Paczkowska, A., Hoffmann, K., Michalak, M., Hans-Wytrychowska, A., Bryl, W., Kopciuch, D., Zaprutko, T., Ratajczak, P., Nowakowska, E., and Kus, K. (2022). Safety Profile of COVID-19 Vaccines among Healthcare Workers in Poland. Vaccines, 10.","DOI":"10.3390\/vaccines10030434"},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Sauserien\u0117, J., Liseckien\u0117, I., Neverausk\u0117, V., \u0160epetauskien\u0117, E., Serapinas, D., Ma\u010dinskas, \u0160., \u0160itkauskien\u0117, B., Bajori\u016bnien\u0117, I., Vai\u010di\u016bnien\u0117, R., and Valius, L. (2022). Adverse Events and Immunogenicity of mRNA-Based COVID-19 Vaccine among Healthcare Workers: A Single-Centre Experience. Medicina, 58.","DOI":"10.3390\/medicina58030441"},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"J\u0119\u015bkowiak, I., Wiatrak, B., Grosman-Dziewiszek, P., and Szel\u0105g, A. (2021). The Incidence and Severity of Post-Vaccination Reactions after Vaccination against COVID-19. Vaccines, 9.","DOI":"10.3390\/vaccines9050502"},{"key":"ref_56","unstructured":"Niepo\u017c\u0105dane Odczyny Poszczepienne (2025, October 13). \u201cCztery Powa\u017cne i Jeden Ci\u0119\u017cki Przypadek\u201d. Available online: https:\/\/www.polsatnews.pl\/wiadomosc\/2021-01-12\/fundusz-kompensacyjny-dot-szczepien-minister-zdrowia-przedstawi-szczegoly\/."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/phn.13134","article-title":"Vaccination Hesitancy: To Be Vaccinated, or Not to Be Vaccinated, That Is the Question in the Era of COVID-19","volume":"40","author":"Perrone","year":"2023","journal-title":"Public Health Nurs."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"e40201","DOI":"10.2196\/40201","article-title":"The Prevalence, Features, Influencing Factors, and Solutions for COVID-19 Vaccine Misinformation: Systematic Review","volume":"9","author":"Zhao","year":"2023","journal-title":"JMIR Public Health Surveill."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.vaccine.2022.11.014","article-title":"Misinformation and COVID-19 Vaccine Hesitancy","volume":"41","author":"Zimmerman","year":"2023","journal-title":"Vaccine"},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Pierri, F., Perry, B.L., DeVerna, M.R., Yang, K.-C., Flammini, A., Menczer, F., and Bryden, J. (2022). Online Misinformation Is Linked to Early COVID-19 Vaccination Hesitancy and Refusal. Sci. Rep., 12.","DOI":"10.1038\/s41598-022-10070-w"},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Rzymski, P., Borkowski, L., Dr\u0105g, M., Flisiak, R., Jemielity, J., Krajewski, J., Mastalerz-Migas, A., Matyja, A., Pyr\u0107, K., and Simon, K. (2021). The Strategies to Support the COVID-19 Vaccination with Evidence-Based Communication and Tackling Misinformation. Vaccines, 9.","DOI":"10.3390\/vaccines9020109"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/s41562-021-01056-1","article-title":"Measuring the Impact of COVID-19 Vaccine Misinformation on Vaccination Intent in the UK and USA","volume":"5","author":"Loomba","year":"2021","journal-title":"Nat. Hum. Behav."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"e2024597118","DOI":"10.1073\/pnas.2024597118","article-title":"Transparent Communication about Negative Features of COVID-19 Vaccines Decreases Acceptance but Increases Trust","volume":"118","author":"Petersen","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/s41586-020-2281-1","article-title":"The Online Competition between Pro- and Anti-Vaccination Views","volume":"582","author":"Johnson","year":"2020","journal-title":"Nature"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1016\/j.vaccine.2014.01.081","article-title":"Understanding Vaccine Hesitancy around Vaccines and Vaccination from a Global Perspective: A Systematic Review of Published Literature, 2007\u20132012","volume":"32","author":"Larson","year":"2014","journal-title":"Vaccine"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/S0140-6736(23)00136-8","article-title":"Confronting the Evolution and Expansion of Anti-Vaccine Activism in the USA in the COVID-19 Era","volume":"401","author":"Carpiano","year":"2023","journal-title":"Lancet"},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Rahmani, K., Shavaleh, R., Forouhi, M., Disfani, H.F., Kamandi, M., Oskooi, R.K., Foogerdi, M., Soltani, M., Rahchamani, M., and Mohaddespour, M. (2022). The Effectiveness of COVID-19 Vaccines in Reducing the Incidence, Hospitalization, and Mortality from COVID-19: A Systematic Review and Meta-Analysis. Front. Public Health, 10.","DOI":"10.3389\/fpubh.2022.873596"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"2027160","DOI":"10.1080\/21645515.2022.2027160","article-title":"The Efficacy and Effectiveness of the COVID-19 Vaccines in Reducing Infection, Severity, Hospitalization, and Mortality: A Systematic Review","volume":"18","author":"Mohammed","year":"2022","journal-title":"Hum. Vaccin. Immunother."},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Damijan, J.P., Damijan, S., and Kostevc, \u010c. (2022). Vaccination Is Reasonably Effective in Limiting the Spread of COVID-19 Infections, Hospitalizations and Deaths with COVID-19. Vaccines, 10.","DOI":"10.21203\/rs.3.rs-1129457\/v1"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41577-020-00451-5","article-title":"COVID-19 Herd Immunity: Where Are We?","volume":"20","author":"Fontanet","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1001\/jama.2020.20892","article-title":"Herd Immunity and Implications for SARS-CoV-2 Control","volume":"324","author":"Omer","year":"2020","journal-title":"JAMA"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.1016\/j.jinf.2020.03.027","article-title":"Herd Immunity\u2013Estimating the Level Required to Halt the COVID-19 Epidemics in Affected Countries","volume":"80","author":"Kwok","year":"2020","journal-title":"J. Infect."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1016\/j.vaccine.2021.04.042","article-title":"Modelling of COVID-19 Vaccination Strategies and Herd Immunity, in Scenarios of Limited and Full Vaccine Supply in NSW, Australia","volume":"40","author":"MacIntyre","year":"2022","journal-title":"Vaccine"},{"key":"ref_74","first-page":"e33575","article-title":"Herd Immunity to Fight Against COVID-19: A Narrative Review","volume":"15","author":"Suryawanshi","year":"2023","journal-title":"Cureus"},{"key":"ref_75","unstructured":"(2025, August 29). Achieving 70% COVID-19 Immunization Coverage by Mid-2022. Available online: https:\/\/www.who.int\/news\/item\/23-12-2021-achieving-70-COVID-19-immunization-coverage-by-mid-2022."},{"key":"ref_76","unstructured":"(2025, August 29). COVID-19 Vaccine Tracker. Available online: https:\/\/vaccinetracker.ecdc.europa.eu\/public\/extensions\/COVID-19\/vaccine-tracker.html."},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Roy, D.N., Biswas, M., Islam, E., and Azam, M.S. (2022). Potential Factors Influencing COVID-19 Vaccine Acceptance and Hesitancy: A Systematic Review. PLoS ONE, 17.","DOI":"10.1371\/journal.pone.0265496"},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Kumar, S., Shah, Z., and Garfield, S. (2022). Causes of Vaccine Hesitancy in Adults for the Influenza and COVID-19 Vaccines: A Systematic Literature Review. Vaccines, 10.","DOI":"10.3390\/vaccines10091518"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"2549164","DOI":"10.1080\/21645515.2025.2549164","article-title":"A Cross-Sectional Study of the Predictors of COVID-19 Vaccine Hesitancy in Pakistan","volume":"21","author":"Ahmad","year":"2025","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Ifeanyi, C., Okechukwu, E., Tosin, O., Hyacinth, I., Ataguba, J.E.-O., Muriithi, G.N., Achala, D.M., Adote, E.N.A., Mbachu, C.O., and Beshah, S.A. (2025). Assessing the Determinants of Uptake and Hesitancy in Accessing COVID 19 Vaccines in Nigeria: A Scoping Review. Front. Health Serv., 5.","DOI":"10.3389\/frhs.2025.1609418"},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Beshah, S.A., Adem, J.B., Degefa, M.B., Ayalew, M., Lakew, Y., Garoma, S., Adote, E.N.A., Achala, D.M., Muriithi, G.N., and Mbachu, C.O. (2025). COVID-19 Vaccine Hesitancy in Ethiopia: A Scoping Review for Equitable Vaccine Access. Front. Health Serv., 5.","DOI":"10.3389\/frhs.2025.1609752"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"527","DOI":"10.3961\/jpmph.25.137","article-title":"COVID-19 Vaccine Acceptance and Hesitancy: Perceptions in Kerala, the Indian State with the Highest Literacy","volume":"58","author":"Muralidharan","year":"2025","journal-title":"JPMPH"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1038\/s41591-024-02939-2","article-title":"Influence of COVID-19 on Trust in Routine Immunization, Health Information Sources and Pandemic Preparedness in 23 Countries in 2023","volume":"30","author":"Lazarus","year":"2024","journal-title":"Nat. Med."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1001\/jamaoncol.2025.2020","article-title":"COVID-19 Vaccine Booster Uptake and Effectiveness Among US Adults with Cancer","volume":"11","author":"Skarbinski","year":"2025","journal-title":"JAMA Oncol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"2437921","DOI":"10.1080\/21645515.2024.2437921","article-title":"Analysis of Public Opinion Polls about COVID-19 Vaccines: Theoretical and Policy Implications for Vaccine Communication and Campaigns to Address Vaccine Hesitancy","volume":"20","author":"Ittefaq","year":"2024","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"127529","DOI":"10.1016\/j.vaccine.2025.127529","article-title":"COVID-19 Vaccine Hesitancy and Perceived Post-Vaccination Adverse Event: Findings from a Cross-Sectional Survey","volume":"62","author":"Dionne","year":"2025","journal-title":"Vaccine"},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Limbu, Y.B., and Huhmann, B.A. (2023). Why Some People Are Hesitant to Receive COVID-19 Boosters: A Systematic Review. TropicalMed, 8.","DOI":"10.3390\/tropicalmed8030159"},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Lorent, D., Nowak, R., Figlerowicz, M., Handschuh, L., and Zmora, P. (2024). Anti-SARS-CoV-2 Antibodies Level and COVID-19 Vaccine Boosters among Healthcare Workers with the Highest SARS-CoV-2 Infection Risk\u2014Follow Up Study. Vaccines, 12.","DOI":"10.3390\/vaccines12050475"},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Luo, C., Chen, H.-X., and Tung, T.-H. (2022). COVID-19 Vaccination in China: Adverse Effects and Its Impact on Health Care Working Decisions on Booster Dose. Vaccines, 10.","DOI":"10.3390\/vaccines10081229"},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Walkowiak, M.P., Domaradzki, J., and Walkowiak, D. (2023). Are We Facing a Tsunami of Vaccine Hesitancy or Outdated Pandemic Policy in Times of Omicron? Analyzing Changes of COVID-19 Vaccination Trends in Poland. Vaccines, 11.","DOI":"10.3390\/vaccines11061065"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"2031455","DOI":"10.1080\/21645515.2022.2031455","article-title":"A Qualitative Insight into the Perceptions and COVID-19 Vaccine Hesitancy among Pakistani Pharmacists","volume":"18","author":"Yaseen","year":"2022","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Nuwarda, R.F., Ramzan, I., Weekes, L., and Kayser, V. (2022). Vaccine Hesitancy: Contemporary Issues and Historical Background. Vaccines, 10.","DOI":"10.3390\/vaccines10101595"},{"key":"ref_93","unstructured":"(2025, August 29). Ten Threats to Global Health in 2019. Available online: https:\/\/www.who.int\/news-room\/spotlight\/ten-threats-to-global-health-in-2019."},{"key":"ref_94","unstructured":"(2025, August 29). Measles on the Rise Again in Europe: Time to Check Your Vaccination Status. Available online: https:\/\/www.ecdc.europa.eu\/en\/news-events\/measles-rise-again-europe-time-check-your-vaccination-status."},{"key":"ref_95","unstructured":"(2025, August 29). Immunization, Available online: https:\/\/www.cdc.gov\/nchs\/fastats\/immunize.htm."},{"key":"ref_96","unstructured":"(2025, August 29). Childhood Vaccination Coverage Statistics, England, 2023\u201324. Available online: https:\/\/digital.nhs.uk\/data-and-information\/publications\/statistical\/nhs-immunisation-statistics\/england-2023-24\/6in-1-vaccine#top."},{"key":"ref_97","unstructured":"(2025, August 29). European Region Reports Highest Number of Measles Cases in More than 25 years\u2014UNICEF, WHO\/Europe. Available online: https:\/\/www.who.int\/europe\/news\/item\/13-03-2025-european-region-reports-highest-number-of-measles-cases-in-more-than-25-years---unicef--who-europe."},{"key":"ref_98","unstructured":"(2025, August 29). Measles Cases and Outbreaks, Available online: https:\/\/www.cdc.gov\/measles\/data-research\/index.html."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.smrv.2017.06.006","article-title":"Incidence of Narcolepsy after H1N1 Influenza and Vaccinations: Systematic Review and Meta-Analysis","volume":"38","author":"Sarkanen","year":"2018","journal-title":"Sleep Med. Rev."},{"key":"ref_100","unstructured":"(2025, August 29). Reporting and Managing Adverse Vaccination Events, Available online: https:\/\/www.health.gov.au\/topics\/immunisation\/immunisation-information-for-health-professionals\/reporting-and-managing-adverse-vaccination-events."},{"key":"ref_101","unstructured":"(2025, August 29). Vaccine Adverse Event Reporting System (VAERS), Available online: https:\/\/wonder.cdc.gov\/wonder\/help\/vaers.html."},{"key":"ref_102","unstructured":"(2025, August 29). Vaccine Safety and Adverse Events Following Immunisation: The Green Book, Chapter 8, Available online: https:\/\/www.gov.uk\/government\/publications\/vaccine-safety-and-adverse-events-following-immunisation-the-green-book-chapter-8."},{"key":"ref_103","unstructured":"(2025, August 29). Adverse Events Following Immunization (AEFI): Canadian Immunization Guide. Available online: https:\/\/www.canada.ca\/en\/public-health\/services\/publications\/healthy-living\/canadian-immunization-guide-part-2-vaccine-safety\/adverse-events-following.html."},{"key":"ref_104","unstructured":"(2025, August 29). AEFI Surveillance and Response Operational Guidelines, Available online: https:\/\/nhm.gov.in\/New_Updates_2018\/NHM_Components\/Immunization\/Guildelines_for_immunization\/AEFI_Surveillance_and_Response_Operational_Guidelines_2015.pdf."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s40264-023-01302-7","article-title":"Factors Associated with Underreporting of Adverse Drug Reactions by Health Care Professionals: A Systematic Review Update","volume":"46","author":"Costa","year":"2023","journal-title":"Drug Saf."},{"key":"ref_106","doi-asserted-by":"crossref","unstructured":"Shekhar, R., Sheikh, A.B., Upadhyay, S., Singh, M., Kottewar, S., Mir, H., Barrett, E., and Pal, S. (2021). COVID-19 Vaccine Acceptance among Health Care Workers in the United States. Vaccines, 9.","DOI":"10.1101\/2021.01.03.21249184"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"3883","DOI":"10.2147\/IDR.S332792","article-title":"Attitude Towards COVID-19 Vaccination Among Healthcare Workers: A Systematic Review","volume":"14","author":"Hajure","year":"2021","journal-title":"IDR"},{"key":"ref_108","unstructured":"(2025, October 19). Fact Sheet for Healthcare Providers Administering Vaccine (Vaccination Providers). Available online: https:\/\/labeling.pfizer.com\/ShowLabeling.aspx?id=16072&format=pdf."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1002\/cpt.2172","article-title":"A New Era in Pharmacovigilance: Toward Real-World Data and Digital Monitoring","volume":"109","author":"Lavertu","year":"2021","journal-title":"Clin. Pharma Ther."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/pds.5542","article-title":"Mobile Apps for Quick Adverse Drug Reaction Report: A Scoping Review","volume":"32","author":"Parracha","year":"2023","journal-title":"Pharmacoepidemiol. Drug"},{"key":"ref_111","doi-asserted-by":"crossref","unstructured":"Sienkiewicz, K., Burzy\u0144ska, M., Rydlewska-Liszkowska, I., Sienkiewicz, J., and Gaszy\u0144ska, E. (2021). The Importance of Direct Patient Reporting of Adverse Drug Reactions in the Safety Monitoring Process. Int. J. Environ. Res. Public Health, 19.","DOI":"10.3390\/ijerph19010413"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"8","DOI":"10.31373\/ejtcm\/138219","article-title":"Use of Antihistamines for COVID-19 Vaccine Recipients with Risk of Anaphylaxis","volume":"5","author":"Grabowski","year":"2022","journal-title":"Eur. J. Trans. Clin. Med."}],"container-title":["Tropical Medicine and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2414-6366\/10\/11\/320\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T09:50:43Z","timestamp":1763113843000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2414-6366\/10\/11\/320"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,13]]},"references-count":112,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,11]]}},"alternative-id":["tropicalmed10110320"],"URL":"https:\/\/doi.org\/10.3390\/tropicalmed10110320","relation":{},"ISSN":["2414-6366"],"issn-type":[{"value":"2414-6366","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,13]]}}}